<DOC>
	<DOCNO>NCT01298700</DOCNO>
	<brief_summary>This study evaluate long-term safety bimatoprost 0.01 % ophthalmic solution compare bimatoprost 0.03 % ophthalmic solution patient glaucoma ocular hypertension .</brief_summary>
	<brief_title>Long-Term Safety Bimatoprost Ophthalmic Solution Patients With Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Ocular hypertension glaucoma eye Requires intraocular pressure ( IOP ) lower therapy eye Best correct visual acuity 20/100 good eye Ocular seasonal allergy within 2 year Required chronic use ocular medication study ( intermittent use artificial tear allow ) Ocular surgery laser within 3 month Anticipated wear contact lens study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>